HCA Healthcare Earnings Insights: Q3 2024 Financial Performance Overview
HCA Healthcare's Impressive Q3 2024 Results
HCA Healthcare, Inc. (NYSE: HCA) announced a remarkable financial performance for the third quarter ended September 30, 2024. Revenue surged by 8% year-over-year, reaching $17.5 billion. Net income attributable to the company also increased significantly to $1.27 billion, or $4.88 per share, compared to $1.08 billion or $3.91 per share in the previous year.
Key Financial Metrics
- Adjusted EBITDA for Q3 totaled $3.27 billion, a notable growth from $2.88 billion in Q3 2023.
- Cash flows from operating activities amounted to $3.52 billion.
- Capital expenditures, excluding acquisitions, reached $1.19 billion during this quarter.
Future Outlook and Shareholder Returns
HCA Healthcare anticipates that total capital expenditure, excluding acquisitions, will be around $5 billion for the entirety of fiscal 2024. Additionally, in Q3, 4.95 million shares of its common stock were repurchased for $1.8 billion. Moreover, the board declared a quarterly cash dividend of $0.66 per share, set to be paid on December 27, 2024.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.